TIAR-dependent coordination of alternative splicing and lipid peroxidation is required for CML cell resistance to imatinib in the bone marrow stroma
Paulina Podszywalow‐Bartnicka, Ewa Kozłowska, Remigiusz Adam Serwa…·Karla M. Neugebauer
Author
Instytut Biologii Doświadczalnej im. Marcelego NenckiegoORCID 0000-0002-4965-828XUnclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Paulina Podszywalow‐Bartnicka, Ewa Kozłowska, Remigiusz Adam Serwa…·Karla M. Neugebauer
Paulina Podszywalow‐Bartnicka, Morgan Shine, Jing Lin, Karla M. Neugebauer
The paper quantifies transcriptional readthrough in CML cells after imatinib treatment and shows it precedes alternative splicing changes and resistance development.
Bac Viet Le, Umeshkumar M. Vekariya, Monika Maria Toma…·Tomasz Skórski
This study identifies Polθ as a therapeutic target in DNMT3A-mutated leukemia by showing its essential role in DNA repair and replication fork restart, and demonstrates that its inhibition enhances standard therapies.
Leonard Schärfen, Pernille Bech, Paulina Podszywalow‐Bartnicka, Karla M. Neugebauer
This study investigates how intron RNA structure affects gene expression using reporter assays and machine learning, finding that base pairing significantly modulates mRNA and protein levels.
Magdalena Rudzińska, Laura Turos-Korgul, Debjita Mukherjee…·Jan Guzowski
This paper develops a high-throughput microfluidic system to generate reproducible 3D leukemia microenvironments for drug testing, showing that stroma-leukemia interactions protect cells from drug-induced cytotoxicity.